Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines (excluding RNAi therapeutics) to treat human disease in ways that were not previously possible. We’re  building a first-in-kind platform designed to sit at the intersection of RNA technology delivery methods, data science and automation to develop an expansive portfolio of medicines, initially focused in the areas of vaccines, immunomodulation, protein replacement and regenerative medicine. 

Founded by experts in the fields of genetic medicine and RNA development and delivery, we have a dynamic operational structure designed to harness the ingenuity of a deep and diverse team of scientists, drug developers and business leaders.

Newpath Management

Andreessen Horowitz

ARCH Venture Partners

Orbital Therapeutics

Orbital Therapeutics CSO, Dr. Gilles Besin, pictured here with Dr. Katalin Karikó, Nobel Prize Winner in Physiology or Medicine (2023), recently attended “Cracking the Code: The Dawn of Nucleic Acid Medicines” conference at Worcester Polytechnic Institute, where speakers discussed recent clinical successes, and current and upcoming challenges in the development of nucleic acid medicines! #CrackingTheCode23 #JoinOurOrbit

Do you have deep expertise successfully leading IND-enabling studies related to LNP/RNA? If so, there may be an available position open for you here at Orbital! Apply here to #JoinOurOrbit.

Congratulations to Orbital Co-Founder, Drew Weissman, on the 2023 Nobel Prize in Physiology or Medicine. Dr. Weissman and Katalin Karikó were jointly awarded the prize, “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.” https://lnkd.in/g8-xG_b #JoinOurOrbit

We're excited to share that Orbital has been named as one of Biopharma's most promising startups in 2023! We're proud to be named to Endpoints 11. Congratulations, Orbiters! #JoinOurOrbit

Last week Orbital celebrated 1-year with a harbor cruise in San Francisco! Cheers to a great day and an even better year, Orbiters! #JoinOurOrbit

Kristen Ott's RNA Platform team here at Orbital is growing! We are looking for talented individuals with experience in both molecular biology and biochemistry to be a part of the design, production, and characterization of novel RNA molecules. Apply here! #JoinOurOrbit

Happy 1-year anniversary, Orbiters! It's been an exciting first year of defining new frontiers of science to lead the future of RNA medicines #JoinOurOrbit

With the combination of high caliber science, revolutionary technologies, a world-class team and an extraordinary team environment, Orbital is aiming to be a therapeutically transformational company. Check out some of our available openings below to #JoinOurOrbit!

https://lnkd.in/e5bfcMSy

Orbital’s CSO Gilles BESIN will be leading the discussion on Circular RNA, a RNA Platform for RNA Medicines at the mRNA Conference 2023 in Boston on August 28 – 29th! #JoinOurOrbit https://lnkd.in/eXyd4yPM

Chief Legal Officer

Chief Legal Officer and Secretary

Member, Board of Directors

SVP, General Counsel, Head of Corporate Operations and Secretary

Counsel/Associate

Chief Legal Officer at Orbital Therapeutics

Jeff Munsie

Associate Director, mRNA Sciences

Senior Scientist, mRNA Sciences

Scientist II, Molecular & Viral Vector Biology

Scientist I, Molecular & Viral Vector Biology

Graduate Student - Molecular Microbiology (PhD)

Research Coordinator

Assistant Research Coordinator

Research & Teaching Specialist V

RNA and MolBio

Robert Blakemore

Chief Scientific Officer

Scientific Advisory Board Member

Vice President, Head of Discovery Research

Head, Discovery research

Sr. Director, Immunology

Director, Immunology

R&D Operations manager

Head, Immunology

Project leader in molecular Biology

Post-Doctoral Position in Immunolgy

CSO Orbital Therapeutics

Gilles Besin

Director of Data Sciences

Principal Data Scientist

Senior Data Scientist II

Graduate Research Fellow

Data Scientist

Computational Biologist

Graduate Student

Research Staff

Director of Data Sciences @OrbitalTx

Benjamin Holmes

Chief Financial Officer

Chief Financial Officer at Orbital Therapeutics

Jonathan Piazza

Director, Protein Replacement

Director, Gene Therapy Research

Principal Scientist

Senior Scientist

Research Scientist

Scientist

Postdoctoral Fellow

Research Associate

Group Leader | RNA Therapeutics | Cell & Gene Therapy | Viral Genomics

Christian Matranga

Associate Director, Biology and Pharmacology

Biopharma Consultant

Associate Director of Biology and Pharmacology

Senior Scientist - Pharmacology

Scientist II - Pharmacology

Scientist II, Translational Biology

Pharmacology Scientist

Scientist II

Scientist I

PhD researcher

PhD Graduate Student

Undergraduate Researcher               Advisor

Nick Snead

Chief Operating Officer

Senior Vice President, Corporate Development & Business Planning

Vice President, Portfolio Strategy and Alliance Management

Vice President, Vaccines Business Transition Lead (2014 – 2015)

Vice President, Head Influenza Global Programs

Senior Director US Marketing, Influenza & Specialty Vaccines

Project leader

Chief Operating Officer at Orbital Therapeutics

Nirupama Subramanian

Associate Director

Senior Scientist, Immunology at Valera LLC

Scientist, Immunology at Valera LLC

Post-Doctoral Associate

Research Technician

Director, Immunology at Orbital Tx

Kapil Bahl

Associate Director, Immunology

Principal Scientist - Immuno-oncology

Senior Scientist - Immuno-oncology

Scientist - Immunology

Scientific Collaborator

PhD in Immunology and Polymer Science

Intern

BEST Autumn Course

Student Assistant

Emrah Ozay

Associate Director, Non-Clinical Sciences

Senior Manager - In Vivo Pharmacology, Immunotherapy

Scientist II - In Vivo Pharmacology, Immunotherapy

Scientist - In Vivo Pharmacology, Toxicology, and Biodistribution

Senior Associate Scientist II - Neuroscience, Preclinical Pharmacology, & Drug Delivery

Senior Associate Scientist - Neuroscience, Preclinical Pharmacology, & Drug Delivery

Associate Scientist

In Vivo Pharmacologist - Gene & Cell Therapy

Allyse Mazzarelli

Director, Non-Viral Delivery

Principal Scientist, Formulation Discovery, Moderna Genomics

Sr. Scientist, Formulation Science

Scientist, Formulation Design

Doctoral Candidate in Bioengineering

Captain

Research Assistant

Director, Non-Viral Delivery at Orbital Therapeutics

Benjamin Geilich

Director

Associate Director, RNA Biology

Senior Scientist, Platform Innovation Lead

Principal Research Associate

Senior Research Associate

Undergraduate Researcher

Director @ Orbital Therapeutics | RNA Sciences

Kristen Ott

Further pushing the limits of RNA Tx modalities | Associate Director

Principal Scientist -RNA Therapeutics

PhD. student (laboratory of Dr. Donald Burke)

Further pushing the limits of RNA Tx modalities | Associate Director at Orbital Therapeutics

Raghav Poudyal

Sr. Director, IT

Head Of Information Technology

Principal Consultant

Consultant

Co-founder

Systems Engineer

Technical Marketing Engineer

Sinisa Baranac

Director, Business Operations

Head of Business Operations

Associate Director, Business Operations

Executive Assistant

Manager, Events and Administration

Director, Business Operations at Orbital Therapeutics

Tracey Cole

Senior Director, Alliance Management

Director R&D Alliance Management

Program Management

Panel Member

R&D Project Leader

Cristina Hehir

Associate Director, Lab Operations

Laboratory Operations Manager

Senior RMA

Lab Operations

Lab Tech

Shiva Anand

Business Operations Consultant

Head of Business Operations & Operations Consultant

Tracey Dembro

Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines (excluding RNAi therapeutics) to treat human disease in ways that were not previously possible. They are building a first-in-kind platform at the intersection of RNA technology, delivery methods, data science, and automation to develop an expansive portfolio of medicines, initially focused in the areas of vaccines, immunomodulation, protein replacement, and regenerative medicine.

news impact assignment basic	general
public peers	general
news daily refresh	general	Aug 6, 2024 11:50 PM	5b59e62f
news processing daily refresh	general	May 23, 2024 4:40 AM	cf5a89d6
news impact assignment daily	general	May 23, 2024 4:40 AM	942fa285
news processing basic	general
company summary	general	May 23, 2024 4:43 AM	6cef819c
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:ORBITALTX

Orbital Therapeutics